Fulminant lactic acidosis in two patients with Type 2 diabetes treated with metformin

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Diabetic Medicine

• Publication date

  2005-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1464-5491.2005.01650.xPMID 16176212
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metformin and thiazolidinedione use in Medicare patients with heart failure.

  2003cited by this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

  2003cited by this paper
• Safety issues on metformin use.

  2003cited by this paper
• Frequency of inappropriate metformin prescriptions.

  2002cited by this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

  2002cited by this paper
• When are medication side effects due to the nocebo phenomenon

  2002cited by this paper
• Inappropriate prescription for metformin.

  2002cited by this paper
• Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications.

  2002cited by this paper
• Inappropriate prescription for metformin.

  2002cited by this paper
• Inappropriate prescription for metformin [2] (multiple letters)

  2002cited by this paper
• Use of base in the treatment of severe acidemic states.

  2001cited by this paper
• Mechanism by which metformin reduces glucose production in type 2 diabetes.

  2000cited by this paper
• Incidence of lactic acidosis in metformin users.

  1999cited by this paper
• A Risk-Benefit Assessment of Metformin in Type 2 Diabetes Mellitus

  1999cited by this paper
• Long-term follow-up of acute renal failure caused by angiotensin converting enzyme inhibitors.

  1998cited by this paper
• Contraindications to Metformin Therapy in Patients With NIDDM

  1997cited by this paper
• Alkali therapy extends the period of survival during hypoxia: studies in rats.

  1996cited by this paper
• Metformin-associated lactic acidosis in diabetic patients with acute renal failure. A critical analysis of its pathogenesis and prognosis.

  1994cited by this paper
• Angiotensin-converting enzyme inhibitors in heart failure: blood pressure changes after the first dose.

  1993cited by this paper
• Definition of clinically relevant lactic acidosis in patients with internal diseases.

  1983cited by this paper

• Metformin-associated lactic acidosis reported to the United Kingdom National Poisons Information Service (NPIS) between 2010 and 2019: a ten-year retrospective analysis

  2023cites this paper
• Effect of Zingiber officinale and Nigella sativa on Streptozotocin-Diabetic Rats with Reference to Biochemical and Hematological Studies

  2020cites this paper
• The Association between Metformin Therapy and Lactic Acidosis

  2019cites this paper
• Is it necessary to discontinue metformin in diabetic patients with GFR > 60 ml/min per 1.73 m2 undergoing coronary angiography: A controversy still exists?

  2018cites this paper
• Metformin-associated lactic acidosis: Current perspectives on causes and risk.

  2016cites this paper
• Acute renal failure and metformin-associated lactic acidosis following colonoscopy.

  2014cites this paper
• The Role of Metformin in Metformin-Associated Lactic Acidosis (MALA): Case Series and Formulation of a Model of Pathogenesis

  2013cites this paper
• Dansk Nyremedicinsk Forskning

  2012cites this paper
• Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements

  2011cites this paper
• Clinical evaluation of Dyslipidemia among type II diabetic patients at Public hospital Penang, Malaysia

  2010cites this paper
• Perioperative use of metformin in cardiac surgery.

  2010cites this paper
• Impact of Metformin on Immunity and Male Fertility in Rabbits with Alloxan-Induced Diabetes

  2010cites this paper
• Prescribing metformin in type 2 diabetes with a contraindication: prevalence and outcome

  2009cites this paper
• METFORMIN AND LACTIC ACIDOSIS IN PATIENTS WITH TYPE 2 DIABETES – FROM PRIDE AND PREJUDICE TO SENSE AND SENSIBILITY

  2009influential citation
• Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice.

  2008cites this paper
• Defining the Role of Repaglinide in the Management of Type 2 Diabetes Mellitus

  2007cites this paper
• Quelles sont les recommandations concernant l’acidose lactique associée à la metformine ?

  2007cites this paper
• Metformin-associated lactic acidosis treated with continuous renal replacement therapy.

  2006cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2006cites this paper
• Use of an electronic medical record to detect patients at high risk of metformin-induced lactic acidosis.

  2006cites this paper